Daniel Shouval
#160,139
Most Influential Person Now
Researcher
Daniel Shouval's AcademicInfluence.com Rankings
Daniel Shouvalcomputer-science Degrees
Computer Science
#9126
World Rank
#9589
Historical Rank
Computational Linguistics
#2160
World Rank
#2182
Historical Rank
Machine Learning
#3919
World Rank
#3966
Historical Rank
Artificial Intelligence
#4253
World Rank
#4312
Historical Rank
Download Badge
Computer Science
Daniel Shouval's Degrees
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Daniel Shouval Influential?
(Suggest an Edit or Addition)Daniel Shouval's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Telaprevir for previously untreated chronic hepatitis C virus infection. (2011) (2539)
- Telaprevir for retreatment of HCV infection. (2011) (1630)
- EASL Clinical Practice Guidelines: management of chronic hepatitis B. (2009) (1471)
- Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. (2006) (1210)
- Statements from the Taormina expert meeting on occult hepatitis B virus infection. (2008) (784)
- Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. (1981) (693)
- Hepatitis B vaccines. (2003) (594)
- A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. (1992) (494)
- p53 mutation in hepatocellular carcinoma after aflatoxin exposure (1991) (478)
- The global impact of vaccination against hepatitis B: a historical overview. (2008) (425)
- Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies (2007) (316)
- Incidence of hepatitis A in Israel following universal immunization of toddlers. (2005) (245)
- Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: A concise review (2000) (242)
- Hepatitis A booster vaccination: is there a need? (2003) (225)
- Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line (1980) (224)
- Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. (2017) (193)
- Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. (2003) (189)
- Relapsing Hepatitis A Review of 14 Cases and Literature Survey (1992) (186)
- Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. (2002) (164)
- Immunosuppression and HBV Reactivation (2013) (149)
- EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients (2021) (140)
- Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. (2006) (136)
- Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine. (2006) (133)
- Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. (1993) (129)
- Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. (2007) (126)
- Hepatotoxicity of herbal and dietary supplements: an update (2015) (119)
- Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors (2002) (118)
- Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine (2015) (112)
- Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines. (1994) (112)
- Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy. (2009) (107)
- Tracing hepatitis B virus to the 16th century in a Korean mummy (2012) (106)
- Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis: A Study of 68 Patients (2002) (105)
- The hepatitis B virus–trimera mouse: A model for human HBV infection and evaluation of anti‐HBV therapeutic agents (1999) (101)
- “Silent” presentation of veno‐occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection (1999) (99)
- Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine (2001) (97)
- A common-source outbreak of fulminant hepatitis B in a hospital. (1989) (89)
- Albinterferon alfa‐2b dosed every two or four weeks in interferon‐naïve patients with genotype 1 chronic hepatitis C (2008) (84)
- Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation (2001) (83)
- Preclinical Evaluation of Two Human Anti–Hepatitis B Virus (HBV) Monoclonal Antibodies in the HBV‐Trimera Mouse Model and in HBV Chronic Carrier Chimpanzees (2000) (82)
- Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: Safety and antiviral properties (2002) (82)
- Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. (1993) (82)
- Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology (2008) (79)
- Clotting factors and hepatitis A (1992) (79)
- Fluidity of membrane lipids and lateral mobility of concanavalin A receptors in the cell surface of normal lymphocytes and lymphocytes from patients with malignant lymphomas and leukemias. (1977) (76)
- Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries (2008) (71)
- The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference (2013) (71)
- Hyper-IL-6 gene therapy reverses fulminant hepatic failure. (2001) (70)
- Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome. (2000) (68)
- Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis. (1993) (67)
- Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine. (2001) (63)
- Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults. (1999) (63)
- Comparison of methods for extraction of nucleic acid from hemolytic serum for PCR amplification of hepatitis B virus DNA sequences (1997) (58)
- Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity. (2001) (58)
- Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients (2000) (57)
- Prevention of hepatitis C virus infection * (2004) (56)
- Detection and characterization of hepatitis B virus DNA in serum of HBe antigen‐negative HBsAg carriers (1984) (55)
- p53 expression in patients with cirrhosis with and without hepatocellular carcinoma (1995) (53)
- Vasculitis and cryoglobulinemia associated with persisting cholestatic hepatitis A virus infection. (1990) (53)
- Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. (1994) (52)
- Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine. (2014) (52)
- Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines – A systematic review (2016) (48)
- Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors (1993) (47)
- Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies. (1980) (47)
- Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus. (1995) (46)
- Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors (1994) (46)
- Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. (1999) (43)
- Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma. (2013) (43)
- Late cytomegalovirus disease following liver transplantation (2002) (39)
- Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity. (1992) (39)
- Immunotherapy in nude mice of human hepatoma using monoclonal antibodies against hepatitis B virus (1982) (37)
- Human hepatoma‐associated cell surface antigen: Identification and characterization by means of monoclonal antibodies (1985) (37)
- Reduced hepatitis B virus surface antigen–specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen‐specific antibodies in the Trimera mouse (2000) (36)
- Reactogenicity and immunogenicity of a new recombinant hepatitis B vaccine containing Pre S antigens: a preliminary report (1996) (35)
- Papular Acrodermatitis of Childhood Associated with Hepatitis A Virus Infection (1985) (35)
- Transient Transmission of Hepatitis C Virus from Mothers to Newborns (2000) (34)
- Endotipsitis‐persistent infection of transjugular intrahepatic portosystemic shunt: pathogenesis, clinical features and management (2010) (33)
- Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo. (2000) (33)
- In Vivo expression of two novel tumor‐associated antigens and their use in immunolocalization of human hepatocellular carcinoma (1989) (33)
- 45 Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(−) chronic hepatitis B patients (study ETV-027) (2006) (33)
- Acute hepatitis E virus in pregnant women in Israel and in other industrialized countries. (2015) (31)
- Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity. (1992) (30)
- Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination. (2008) (30)
- Detection of alpha-foetoprotein messenger RNA in human hepatocellular carcinoma and hepatoblastoma tissue. (1986) (30)
- Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon (2003) (30)
- Antigenic characterization of human hepatocellular carcinoma. Development of in vitro and in vivo immunoassays that use monoclonal antibodies. (1985) (29)
- Viral envelope-specific antibodies in chronic hepatitis B virus infection. (2018) (29)
- Continuous production of erythropoietin by an established human renal carcinoma cell line: development of the cell line. (1986) (29)
- Stimulation by cAMP of erythropoietin secretion by an established human renal carcinoma cell line. (1987) (29)
- Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation (1999) (28)
- Genotypic and Phenotypic Resistance: Longitudinal and Sequential Analysis of Hepatitis B Virus Polymerase Mutations in Patients With Lamivudine Resistance After Liver Transplantation (2003) (28)
- Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin. (1993) (28)
- Postpartum Budd-Chiari syndrome with prolonged hypercoagulability state. (1990) (27)
- Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. (1995) (27)
- Chronic hepatitis and other liver disease (2009) (27)
- Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen. (1982) (27)
- Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA. (1981) (26)
- Sequence Variability of Hepatitis A Virus and Factor VIII Associated Hepatitis A Infections in Hemophilia Patients in Europe: An Update (1994) (26)
- Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus. (1983) (26)
- Immunization against hepatitis B through adoptive transfer of immunity. (1995) (25)
- Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk (1991) (25)
- The case for simplifying and using absolute targets for viral hepatitis elimination goals (2020) (24)
- Hepatitis during measles in young adults: Possible role of antipyretic drugs (1989) (24)
- Hepatitis A and B vaccination and public health (2007) (23)
- Exposure to hepatitis B and C and to HTLV-1 and 2 among Israeli drug abusers in Jerusalem. (1994) (23)
- An acupuncture-associated outbreak of hepatitis B in Jerusalem (1988) (23)
- Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens. (1988) (22)
- Trans‐arterial chemo‐embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database (2014) (21)
- Hepatitis C Virus Infection in Employees of a Large University Hospital in Israel (2001) (21)
- Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients. (2001) (20)
- Breastmilk hepatitis A virus RNA in nursing mothers with acute hepatitis A virus infection. (2012) (20)
- Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules. (2007) (20)
- Hepatitis-C-associated cryoglobulinemia after liver transplantation. (1995) (20)
- [An outbreak of hepatitis B associated with acupuncture]. (1989) (20)
- Chronic hepatitis C virus infection with exposure to hepatitis B virus. (1994) (20)
- Premature appearance of hepatic phosphoenolpyruvate carboxykinase in fetal rats, not mediated by adenosine 3':5'-monophosphate. (1979) (19)
- Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper (2022) (19)
- Radioimmunolocation of hepatic and pulmonary metastasis of human colon adenocarcinoma. (1989) (19)
- Suppression of human hepatoma in mice through adoptive transfer of immunity to the hepatitis B surface antigen. (1997) (19)
- Liver failure and the sea-blue histiocyte/adult Niemann-Pick disease. Case report and review of the literature. (1992) (19)
- Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantation (2004) (18)
- A conjugate of 5-fluorouridine-poly(L-lysine) and an antibody reactive with human colon carcinoma. (1990) (18)
- THREE YEARS OF ENTECAVIR (ETV) RE-TREATMENT OF HBEAG(-) ETV PATIENTS WHO PREVIOUSLY DISCONTINUED ETV TREATMENT: RESULTS FROM STUDY ETV-901. 30 Oct-4 Nov, Moscone West Convention Center, San Francisco (2009) (18)
- Esophageal malignancy after liver transplantation in a patient with Barrett's esophagus. (1996) (18)
- REDUCED INCIDENCE OF HYPERURICEMIA, GOUT, AND RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION IN COMPARISON TO HEART TRANSPLANTATION: A LONG-TERM FOLLOW-UP STUDY (2004) (18)
- Hepatocellular carcinoma. (1998) (17)
- Commonly Found Variations/Mutations in the HBsAg of Hepatitis B Virus in the Context of Effective Immunization Programs: Questionable Clinical and Public Health Significance (2014) (16)
- Chronic active hepatitis with cholestatic features. I. A clinical and immunological study. (1979) (16)
- Clofibrate does not induce peroxisomal proliferation in human hepatoma cell lines PLC/PRF/5 and SK-HEP-1. (1987) (15)
- Will transplantation of an hepatitis C-infected graft improve the outcome of liver transplantation in HCV patients? (1999) (15)
- Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial. (1993) (14)
- Adoptive transfer of immunity to HBV in liver transplant patients:A step forward toward the proof of concept for therapeutic vaccination or a transient immunologic phenomenon? (2007) (14)
- IgA deficiency associated with chronic hepatitis C virus infection. A cause or an effect? (1993) (14)
- Comparative morphology and tumourigenicity of human hepatocellular carcinoma cell lines in athymic rats and mice (2004) (13)
- Liver transplantation across the ABO barrier: the role of plasmapheresis. (1998) (13)
- Beneficial effect of ribavirin on hepatitis C-associated cryoglobulinemia after liver transplantation. (1996) (13)
- Immunization against Hepatitis A. (2019) (13)
- Bacteremia and "Endotipsitis" following transjugular intrahepatic portosystemic shunting. (2011) (13)
- 15 – Hepatitis B vaccines (2013) (13)
- Detection of hepatitis a virus rna in serum from patients with acute hepatitis (1989) (13)
- The effect of anti‐α‐fetoprotein‐adriamycin conjugate on a human hepatoma (1990) (12)
- Increased prevalence of HBV envelope mutants in Taiwan: an emerging public health risk or a false alarm? (2012) (12)
- Immunological evaluation of asymptomatic carriers of hepatitis B virus. (1981) (12)
- Strategies for global prevention of hepatitis B virus infection. (2010) (12)
- [Circulating immune complexes in familial Mediterranean fever, systemic lupus erythematosus and HBsAg carriers]. (1979) (11)
- What is the clinical significance of the high prevalence of occult hepatitis B in US liver transplant patients with chronic hepatitis C? (2008) (11)
- The questionable role of immunization against hepatitis B in HBV infected liver transplant patients. (2005) (11)
- Hospital related morbidity from chronic hepatitis C virus (HCV) infection in Australia and mortality from HCV infection in a population cohort in Denmark: two complementary studies relevant to counseling patients. (2010) (11)
- Active immunization against hepatitis A is now warranted in glucose-6-phosphate dehydrogenase-deficient subjects. (1996) (11)
- Case Report: Liver-Spleen Infarcts Following Transcatheter Chemoembolization (A Case Report and Review of the Literature on Adverse Effects) (1997) (11)
- Immunogenicity of a Mammalian Cell-derived Recombinant Hepatitis B Vaccine Containing Pre S2 and Pre S1 Antigens: A Preliminary Report (1994) (11)
- Primary biliary cirrhosis in Israel. (1992) (11)
- Development of a novel C1q immunoadsorbent for removal of circulating immunecomplexes: quantitative isolation of hepatitis B virus surface antigen and immunecomplexes. (1985) (11)
- The History of Hepatitis A (2020) (10)
- The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B. (2014) (10)
- Changes in the Con-A-induced redistribution pattern of lymphocytes: a possible aid in the differential diagnosis between malignant lymphoma and other diseases. (1980) (9)
- Evidence for Hepatitis A Virus Endemic Circulation in Israel Despite Universal Toddler Vaccination Since 1999 and Low Clinical Incidence in All Age Groups. (2016) (9)
- Occupational and non-occupational hepatitis B virus infection among hospital employees in Jerusalem: a basis for immunisation strategy. (1992) (9)
- Is universal vaccination against hepatitis B sufficient for control of HBV infection? Lessons from the immunization campaign in Italy. (2000) (9)
- [779] ANTIVIRAL RESPONSE AT WEEK 12 FOLLOWING COMPLETION OF TREATMENT WITH ALBINTERFERON a-2b PLUS RIBAVIRIN IN GENOTYPE 1, IFN-NAIVE, CHRONIC HEPATITIS C PATIENTS (2007) (9)
- Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting report (2016) (9)
- Conjugates between monoclonal antibodies to HBsAg and cytosine arabinoside. (1986) (9)
- Specific targeting of adriamycin conjugates with monoclonal antibodies to hepatoma associated antigens to intrahepatic tumors in athymic mice (1995) (9)
- Focus: quantitative HBsAg measurement as a new surrogate marker for assessment of hepatic fibrosis in HBeAg+ chronic hepatitis B. (2013) (8)
- HCC: What's the score (2002) (8)
- Erythropoietin-induced polycythemia in athymic mice following transplantation of a human renal carcinoma cell line. (1988) (8)
- Transient cortical blindness in hepatic encephalopathy. (1979) (8)
- Hepatitis A virus and polymerase chain reaction amplification: methodology and results. (1995) (8)
- The role of ERCP in biliary complications after liver transplantation. (1999) (8)
- Type B and non-B viral hepatitis in Jerusalem. (1976) (8)
- Evidence for Hepatitis A Virus Endemic Circulation in Israel Despite Universal Toddler Vaccination Since 1999 and Low Clinical Incidence in All Age Groups (2016) (8)
- Measles: Clinical and Laboratory Observations in Young Adults During an Epidemic (1988) (7)
- Improvement of immune-complex nephritis associated with hepatitis B surface antigen excess. (1989) (7)
- 25 – Hepatitis B Vaccines (2018) (7)
- Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines (2005) (7)
- Human and mouse "LAK" cells expanded in long-term cultures: in vitro and in vivo studies. (1987) (7)
- Development of a scaled up liver device incorporating cryo-preserved pig liver micro-organs. (2004) (7)
- Conservation from rat to human of cytosolic phosphoenolpyruvate carboxykinase and the control of its gene expression (1985) (7)
- Air transportation of patients with end‐stage liver disease to distant liver transplantation centers (2005) (7)
- Octreotide in hepatocellular carcinoma (1998) (7)
- Mononeuritis multiplex: a rare complication of acute hepatitis A. (2008) (7)
- Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic mice (2005) (6)
- Continued Virologic Improvement Through 96 Weeks of Entecavir Treatment in HBeAg(-) Chronic Hepatitis B Patients (Study ETV-027) (2006) (6)
- Production of erythropoietin by an established human renal carcinoma cell line: in vitro and in vivo studies. (1988) (6)
- Excessive hepatitis-B surface antigen production after corticosteroids and the development of immunoblastic lymphoma. (1993) (6)
- Nodular regenerative hyperplasia with portal hypertension in a patient with myasthenia gravis. (1987) (6)
- Hepatitis C-associated cryoglobulinemia presenting with pericardial effusion. (1997) (6)
- Hepatitis E in Israel: A nation-wide retrospective study. (2016) (6)
- Focus. What is the significance of hepatitis E as a public health threat in the industrialized countries? Hepatitis E virus infection in Italy. (2011) (6)
- Chronic active hepatitis with cholestatic features. II. A histopathological study. (1979) (6)
- 733 Interim (week 12) phase 2b virological efficacy and safety results of albumin interferon Alpha-2b combined with ribavirin in genotype 1 chronic hepatitis C infection (2006) (5)
- Expanding the donor pool for liver transplant recipients using HBsAg positive grafts. (2014) (5)
- The HBV-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents (1999) (5)
- Adoptive transfer of immunity to hepatitis B : development of the concept and evolution of the research project for targeted immunotherapy against hepatic cells which express a viral antigen (1995) (5)
- Hepatitis: New doubts about preventing HAV superinfection in chronic HCV (2012) (5)
- Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance. (2002) (5)
- Improved immunogenicity in mice of a recombinant hepatitis B vaccine containing preS1 and preS2 antigens in HBs particles (1991) (5)
- Asian Pacific Association for Study of the Liver (APASL) (2003) (4)
- Chronic active hepatitis in Jerusalem: comparison between HBsAg-negative and HBsAg-positive cases. (1978) (4)
- Tumor site-directed therapy for hepatocellular carcinoma using monoclonal antibodies against hepatoma-associated antigens. (1993) (4)
- Severe acute Wilson's disease: An indication for emergency administration of high doses of D-penicillamine (1990) (4)
- Caustic sclerosing cholangitis treated with orthotopic liver transplantation. (2002) (4)
- Increased risk of exposure to hepatitis B infection among butchers sharing knives. (1999) (4)
- Hepatitis A vaccines : impact of universal childhood vaccination programmes (2011) (4)
- Late cytomegalovirus infection occurring two or more years following liver transplantation: a report of seven cases and review of the literature. (2003) (4)
- A finger-stick assay for determination of immunity to hepatitis A: a preliminary report. (1993) (4)
- Vaccination against hepatitis B: a historical overview (2007) (4)
- Natural course of de novo hepatitis B virus infection in liver transplant recipients. (1997) (4)
- Embolization of hepatocellular carcinoma with drug-eluting beads: new insight into the biologic effects of tumor ablation. (2011) (4)
- Hepatitis A Virus (2014) (3)
- Herbalife revisited: Reply (2008) (3)
- Liver micro-organs transcribe albumin and clotting factors and increase survival of 92% hepatectomized rats. (2003) (3)
- Rapid seroprotection against hepatitis B following the ® rst dose of a PreS 1 / PreS 2 / S vaccine (2000) (3)
- [The effect of oral contraceptives on serum immunoglobulins]. (1978) (3)
- Induction of Functional Control in Chronic Hepatitis B Patients with Low Level HBsAg Using a Combination of a PreS1/S2/S HBV Vaccine (Sci-BVacTM) and a Nucleoside Analogue (2019) (3)
- Study of 90 hepatitis B surface antigen carriers in Israel. (1981) (3)
- Hepatitis A vaccine for secondary hepatitis A infection (1999) (3)
- Fatal relapsing viral hepatitis A infection during pregnancy. (1988) (3)
- Residual viral B particles at 10 years post trans-plantation in patients receiving long term anti-HBs immunoglobulins (HBIG) (2000) (3)
- Delta virus infection in Jerusalem. (1988) (3)
- Vaccines for prevention of viral hepatitis (1998) (2)
- Hepatitis C-associated cryoglobulinemia after liver transplantation. (1995) (2)
- Chapter 29 – Hepatitis A (2012) (2)
- Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following liver transplantation? (1997) (2)
- [Transarterial oil chemoembolization for hepatocellular carcinoma, in 100 cases]. (2000) (2)
- Herbalife nutritional products and liver injury revisited (2017) (2)
- Variable efficacy of interferon-alpha treatment on growth of human hepatoma cell lines in vitro. (1988) (2)
- Focusing on the past, present, and future of hepatology. (2014) (2)
- Clotting factors and hepatitis A. Working Group on Hepatitis A and Clotting Factors. (1992) (2)
- TT Virus Infection in Israeli Patients with Fulminant Hepatic Failure (2000) (2)
- Sublines of the Burkitt line Daudi, selected on the basis of reactivity with soybean agglutinin, differ in tumorigenicity in athymic mice. (1988) (2)
- [Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver]. (2012) (2)
- The effect of anti-alpha-fetoprotein-adriamycin conjugate on a human hepatoma. (1990) (2)
- Recombinant DNA and the liver: studies with albumin, alpha-fetoprotein, hepatitis B virus, and other DNA probes. (1982) (2)
- Liver Transplantation and Nursing Care in Israel (2001) (2)
- Human Hepatoma Associated Antigens: Opportunities for Immunotherapy (1994) (1)
- Cost-benefit analysis ofanationwide inoculation programme against viral hepatitis B inanareaofintermediate endemicity (1992) (1)
- [Recommendations of the Hadassah University Hospital Committee for active immunization against hepatitis B virus infection]. (1983) (1)
- Role of vaccination and adoptive immune transfer in persistent hepatitis B virus infection. (2001) (1)
- The impact of fatigue and treatment with ursodeoxycholic acid on the prognosis of primary biliary cirrhosis: an extended 9 year follow-up. (2010) (1)
- The trimera mouse system: A model for HCV infection and evaluation of antiviral drugs (2000) (1)
- The impact of chronic hepatitis C infection on the circadian clock and sleep. (2014) (1)
- Bilirubin conjugates produced by human, dog, and rat hepatocytes transplanted into athymic Gunn rats. (1991) (1)
- The Trimera mouse An HBV and HCV infection model for evaluation of antiviral drugs (1999) (1)
- 1030 TRANS-ARTERIAL CHEMO-EMBOLIZATION (TACE) IS SAFE AND EFFICIENT FOR ELDERLY PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC): RESULTS FROM AN INTERNATIONAL META-DATABASE (2012) (1)
- Hepatitis A Prophylaxis (1996) (1)
- The search for a new endpoint for antiviral prophylaxis in hepatitis B virus transplanted patients. (2010) (1)
- Focus: Long-term treatment with lamivudine in HBeAg negative patients with chronic hepatitis B: to switch or not to switch? (2012) (1)
- Aortic insufficiency unmasked by a peritoneovenous shunt. (1983) (1)
- Entecavir (ETV) treatment through 96 weeks results in virologic and biochemical improvement in HBeAg(-) chronic hepatitis B patients (study ETV-027) (2006) (1)
- Delta virus infection in Jerusalem. (1987) (1)
- More reports of potential hepatotoxicity of Herbalife products: Reply (2008) (1)
- TEMPORARY REMOVAL: Hepatitis A and E - differences and commonalities. (2020) (1)
- Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis (2002) (1)
- Hepatitis B in Chimpanzees (1994) (1)
- DOP64 Pathogenic RIPK1 Mutations Cause Infantile-onset IBD with Inflammatory and Fistulizing Features (2022) (1)
- Rapid formation of specific neutralizing antibodies to HAV following a single dose of an inactivated hepatitis A virus vaccine (1990) (1)
- OP32 Stool microbiome communities predict remission in treatment-naïve Pediatric Crohn’s Disease patients (2021) (1)
- [The role of hepatitis B virus infection in the development of primary hepatocellular carcinoma]. (1985) (0)
- 3 years of ETV re-treatment in HBeAg (-) patients who previously discontinued ETV treatment: results from study ETV-901 (2009) (0)
- Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine (2015) (0)
- Focus. The impact of ribavirin treatment on spermatogenesis inpatients with chronic hepatitis C. (2010) (0)
- WS16.6 Is primary sclerosing cholangitis (PSC) a cystic fibrosis-related disorder? Electrophysiological testing and full sequencing of the CFTR gene (2015) (0)
- Round Table Discussion (1994) (0)
- Histocompatibility antigens and cell-mediated immunity in carriers of hepatitis B virus; a study of a family. (1982) (0)
- Subject Index Vol. 79, 2000 (2000) (0)
- OP16 Characterization of the Clinical Features and Outcomes of Paediatric Patients with Isolated Colonic Crohn’s Disease: A Multi-center Study from the Porto Group of ESPGHAN (2021) (0)
- Daniel Shouval (2010) (0)
- I-61 The changing molecular epidemiology of hepatitis A virus infection in Jerusalem following implementation of universal vaccination in 1999-2004 (2008) (0)
- [Interrelation between liver and bowel involvement in ulcerative colitis patients undergoing liver transplantation]. (1993) (0)
- Pathophysiological changes associated with increasing grade of hepatic encephalopathy. (1988) (0)
- EASL Recognition Award Recipient 2018: Prof. Didier Samuel. (2018) (0)
- Potential short-term mortality risk in patients undergoing entecavir treatment for spontaneous exacerbation of chronic hepatitis B: Fact or bias? (2011) (0)
- Correction of β-glucuronidase deficiency in mice by intrasplenic transplantation of isolated hepatocytes (1995) (0)
- Generation of high affinity, fully human monoclonal antibodies specific to hepatitis B virus in a human/mouse radiation chimera: the trimera system (1998) (0)
- PATHOPHYSIOLOGICAL CHANG ASSOCIATEDWITHINCREASIN GRADEOFHEPATIC ENCEPHALOPATHY (1988) (0)
- The emerging questionable benefit of sorafenib as a neo-adjuvant in HCC patients treated with Y-90 radioembolization pending liver transplantation. (2014) (0)
- Role of Parkin in Acetaminophen-induced Mitophagy and Liver Injury (2013) (0)
- O.127 Phase 2b interim (week 12) results of albumin interferon alpha-2b combined with ribavirin in IFN-naïve, genotype 1 chronic hepatitis C infection (2006) (0)
- A New Vaccine for the Prevention of Hepatitis A: Summary of a Satellite Symposium (1994) (0)
- Endemic circulation of hepatitis a virus in israel in spite of universal vaccination program evidenced by clinical and environmental surveillance (2015) (0)
- Adoptive Transfer of Immunity to Hepatitis B Through Bone Marrow Transplantation from Immunized Donors (1994) (0)
- The hepato-protective effect(s) of three cups of a coffee a day: relevance for patients with chronic hepatitis C (2011) (0)
- The effect of oral contraceptive on serum immunoglobulins (1978) (0)
- P011 Serum adhesion G protein coupled receptor levels are associated with disease activity in pediatric patients with Crohn’s disease (2021) (0)
- Adoptive immune transfer as a therapeutic approach for persistent hepatitis B virus infection (2003) (0)
- 9.16 Chronic hepatitis and other liver disease (2009) (0)
- Expression of P53 in cirrhotic livers adjacent to hepatocellular carcinoma (1994) (0)
- Human liver micro-organs transcribe albumin and clotting factors in an in vivo perfusion model (2000) (0)
- Lack of Evidence of Borrelia Involvement in A lzheimer's D isease (2000) (0)
- OP05 Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS study (2022) (0)
- Laboratory Stigmata of Connective Tissue Disorders in Asymptomatic Carriers of Hepatitis B Virus (1981) (0)
- Viral alcoholic and fatty liver diseases (2021) (0)
- A plastic anemia—associated hepatitis successfully treated by bone marrow transplantation (1998) (0)
- Prevention of Hepatitis A (2019) (0)
- 591 TRANS ARTERIAL CHEMO-EMBOLIZATION (TACE) IS A SAFE AND EFFECTIVE TREATMENT FOR VERY ELDERLY PATIENTS WITH HEPATOCELLULR CARCINOMA (HCC) (2010) (0)
- F5-8 Adoptive transfer of immunity to hepatitis B (1995) (0)
- Hepatotoxicity of herbal and dietary supplements: an update (2015) (0)
- Vaccination against hepatitis B and C: the state of the art (2005) (0)
- One step forward in understanding the differences in antiviral response to interferon a2a and a2b in chronic hepatitis C patients with advanced fibrosis. (2012) (0)
- The ‘ natural ’ course of hepatitis B virus infection as relevant to patients with a haematological malignancy (2007) (0)
- Hepatitis B vaccine failures: how do we handle them? (2020) (0)
- 482 OUTCOME COMPARISON OF PERCUTANEOUS AND SURGICAL INTERVENTIONS IN PATIENTS WITH BUDD-CHIARI SYNDROME- A LONGITUDINAL SINGLE CENTER EXPERIENCE (2009) (0)
- Enhanced tumorigenicity and hepatitis B virus genes in a human hepatoma cell line injected into immunosuppressed nude mice. (1981) (0)
- HBIG in patients liver transplanted with HBc positive donors (2000) (0)
- TypeBandnon-Bviral hepatitis inJerusalem* (1976) (0)
- Prolonged seroprotection with a new HBIG against HBV reinfection after liver transplantation (OLT) (1998) (0)
- Prophylactic lamivudine therapy may prevent immunosuppressive induced HBV reactivation in chronic carriers (2001) (0)
- [The risk of hepatitis C virus infection in health care workers]. (1994) (0)
- Therapeutic Vaccination with a Third Generation PreS/S vaccine (Sci-B-VacTM) with HBV Carriers with Low-level of HBsAg result in Serovonversion to Anti-HBs (2016) (0)
- New insight into the mechanism of hepatic involvement in brucellosis. (2010) (0)
- P.082 Entecavir (ETV) treatment through 96 weeks results in virologic and biochemical improvement in HBeAg(-) chronic hepatitis B patients (study ETV-027) (2006) (0)
- FOCUS (1985) (0)
- Hepatitis E virus in Israel: A nationwide retrospective study, from a non-endemic country (2015) (0)
- Contents Vol. 79, 2000 (2000) (0)
- Images in hepatology. Bone marrow deposits of oxalate crystals. (2000) (0)
- Chapter 44 – Graft-Versus-Host Disease and the Liver (2006) (0)
- Should FibroTest and/or Fibroscan replace liver biopsies in the follow-up of patients treated with low-dose methotrexate? (2010) (0)
- Universal hepatitis A vaccination of young children is leading to disappearance of hepatitis A in adolescents and adults (2003) (0)
- Hepatitis D double reflex testing of all hepatitis B carriers in low HBV and high HBV/high HDV prevalence countries. (2023) (0)
- Bone Marrow Deposits of Oxalate Crystals (2000) (0)
- The HBV trimera mouse: a model for human HBV infection and evaluation of anti-viral agents (1998) (0)
- Interferon, nk cells and tumorigenicity of a human hepatoma cell line secreting hepatitis b surface antigen in immuno- suppressed nude mice. Abstr. (1981) (0)
- [Loaiasis ("Calabar swelling")]. (1983) (0)
- Natural course of HCV viremia following liver transplantation and clinical course of reinfection. (1997) (0)
- Fading expectations regarding the beneficial effect of N-acetylcystein in the treatment of severe alcoholic hepatitis (2010) (0)
- area of intermediate endemicity . inoculation programme against hepatitis B in an Cost-benefit analysis of a nationwide neonatal (0)
- hepatocellular carcinoma andhepatoblastoma tissue (1986) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Daniel Shouval?
Daniel Shouval is affiliated with the following schools:
